CLINICAL_TRIALS
trial_result
· 2012-03-12
Clinical Trial Update: Vandetanib to Treat Advanced Kidney Cancer [Phase 2]
Summary
Phase 2 study of Vandetanib for advanced Clear cell renal cell carcinoma was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Clear Cell Renal Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2012-03-12